In the News

Aadel Chaudhuri, MD, PhD discusses ctDNA liquid biopsy at the Institute of Cancer Research Symposium in Shenzhen, China (Nov 18, 2022)
Aadel Chaudhuri, MD, PhD discusses ctDNA MRD at the Liquid Biopsy Surveillance & Early Detection Summit (Nov 16, 2022)
Aadel Chaudhuri, MD, PhD delivers grand rounds at the London Health Centre at Western University as a Visiting Professor in Radiation Oncology (Nov 8, 2022)
Noah Earland, MSTP student, delivers oral presentation at the ASTRO Annual Meeting (Oct 25, 2022)
Aadel Chaudhuri, MD, PhD delivers Michael Fry Award Lecture at the Radiation Research Society Conference (Oct 17, 2022)
Aadel Chaudhuri, MD, PhD selected as a ASTRO 2022 Social Champion (Oct 14, 2022)
Aadel Chaudhuri, MD, PhD discusses the role of ctDNA in advancing clinical decision-making (Frontline Genomics; Oct 6, 2022)
Aadel Chaudhuri, MD, PhD delivers ERO-RO Research Seminar at the MD Anderson Cancer Center (Oct 5, 2022)
Aadel Chaudhuri, MD, PhD delivers grand rounds at the Mayo Clinic as a Visiting Professor in Radiation Oncology (Sep 23, 2022)
Aadel Chaudhuri, MD, PhD presents at the Tri-Omics Summit (Frontline Genomics; Sep 28, 2022)
Aadel Chaudhuri, MD, PhD presents at the AAADV Workshop on ctDNA for cancer detection (Sep 15, 2022)
Aadel Chaudhuri, MD, PhD gives a research seminar at the Fred Hutchinson Cancer Center in Seattle (Sep 13, 2022)
Researchers take aim at cancer drugs’ toxic side effects (Science; Aug 31, 2022)
Physician Scientist Aadel Chaudhuri wins the Michael Fry Award (PD Soros News; Aug 17, 2022)
New Manuscript Shows Changes in ctDNA Reflect Clinical Benefit to Patients (Friends of Cancer Research; Aug 15, 2022)
Nicholas Semenkovich, MD, PhD wins best poster award at the Cancer Genomics Consortium (Aug 9, 2022)
Aadel Chaudhuri, MD, PhD presents the North American perspective on ctDNA at the World Conference for Lung Cancer (Aug 6, 2022)
Erik Storrs presents in a Podium Presentation at the Cancer Genomics Consortium (Aug 2, 2022)
Aadel Chaudhuri, MD, PhD speaks at Delta Chi National Conference about cancer research (V Foundation; July 28, 2022)
Aadel Chaudhuri, MD, PhD speaks at the Friends of Cancer Research ctDNA panel (July 20, 2022)
Paul Jones highlighted in the WashU Cancer Biology Trainee Corner (July 14, 2022)
Aadel Chaudhuri, MD, PhD speaks at the ASTRO ROCKS session on transitioning from residency to K-funded physician-scientist (July 12, 2022)
V Scholar Earns Prestigious Honor (V Foundation; July 8, 2022)
Chaudhuri recognized by Radiation Research Society (WashU News; July 6, 2022)
Aadel Chaudhuri, MD, PhD wins the Michael Fry Award from the Radiation Research Society (June 23, 2022)
Paul Jones, PhD student, wins the Young Investigator Award from the Children’s Tumor Foundation (June 2, 2022)
Aadel Chaudhuri, MD, PhD invited to give Grand Rounds as Visiting Professor at Dartmouth (May 22, 2022)
Aadel Chaudhuri, MD, PhD speaks at the V Scholar Summit (May 3, 2022)
Under the Microscope: Healing Cancer while Avoiding Harm (V Foundation; May 2, 2022)
Aadel Chaudhuri, MD, PhD speaks at the AstraZeneca T2C Lung Cancer Symposium in Singapore (Apr 19, 2022)
Aadel Chaudhuri, MD, PhD discusses his research at the NIH Liquid Biopsy Scientific Interest Group (Apr 13, 2022)
Pancreatic cancer research at AACR highlighted by Siteman Cancer Center (Siteman; Apr 12, 2022)
Our collaborative research spotlighted in Cancer Cell (Cell Press; March 14, 2022)
Our collaborative research spotlighted in Med (Cell Press; March 11, 2022)
NCI CCR Milestones 2022 – Deciphering DNA Clues (National Cancer Institute; March 9, 2022)
Our collaborative research spotlighted in Trends in Cancer (Cell Press; March 8, 2022)
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma (Nature Medicine; Jan 13, 2022)
Aadel Chaudhuri, MD, PhD discusses his career journey (Washington University Physicians; June 10, 2022)
As liquid biopsy technology improves, cancer research stands to benefit (Nature Portfolio; Nov 10, 2021)
Aadel Chaudhuri, MD, PhD, on Personalizing Treatment for Oligometastatic Cancer (The ASCO Post; Oct 30, 2021)
ctDNA MRD as a biomarker for solid tumors (VJ Oncology; October 28, 2021)
Siteman Cancer Center at ASTRO (Siteman Cancer Center; Oct 26, 2021)
Liquid Biopsies May Drive Earlier Detection, Treatments (Oncology Times; Oct 20, 2021)
Fellows in the News (Paul & Daisy Soros Fellowship; Oct 16, 2021)
Cancers And Sepsis Being Targeted By cfDNA Liquid Biopsies (Diagnostics World; Oct 13, 2021)
Blood-Based Biopsy for Cancer-Predisposed Patients (the Pathologist; Oct 9, 2021)
Novel Test Distinguishes Benign from Malignant Lesions in NF1 (Medscape; Sep 6, 2021)
Blood, urine biopsies could pave way for more personalized cancer therapy (ScienceDaily; Sep 1, 2021)
PLOS Medicine Author Interview: Aadel Chaudhuri, MD, PhD (PLOS Medicine; Aug 31, 2021)
Liquid biopsies may aid diagnosis, treatment of bladder, nerve tumors (WashU News, Aug 31, 2021)
In common genetic disorder, blood test reveals when benign tumors turn cancerous (NIH News, Aug 31, 2021)
Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease (GenomeWeb; Aug 31, 2021)
Blood Testing Distinguishes Benign Tumors From Precancerous Condition (GenomeWeb; Aug 31, 2021)
Liquid Biopsies May Aid Diagnosis, Treatment Of Bladder, Nerve Tumors – Washington University School Of Medicine In St. Louis (Pediatric Daily News; Aug 31, 2021)
Liquid biopsy may help diagnose and treat bladder, neuroma (Florida News Times; Aug 31, 2021)
Editor’s Choice: PLOS Medicine Special Issue: Early Detection and Minimal Residual Disease (PLOS Medicine; Aug 31, 2021)
Liquid biopsies may aid diagnosis, treatment of bladder, nerve tumors (Siteman News, Aug 31, 2021
Chaudhuri Lab awarded MIRA R35 ESI award (R01-equivalent of $1.97 million over 5 years to fund their liquid biopsy research (Aug 23, 2021)
Currently Relegated for Use in Clinical Trials, MRD Is Poised to Expand Further (Targeted Oncology; Aug 16, 2021)
Dr. Chaudhuri and Dr. Chen speak about their liquid biopsy ventures at the ICTS Precision Medicine Venture Cafe (ICTS; May 20, 2021)
Collaborative work on liquid biopsy MPNST sarcoma detection vs. its benign precursor published on medRxiv (medRxiv; April 25, 2021)
Dr. Chaudhuri has been chosen to lead the ctDNA working group within the Solid Tumor Therapeutics Program (STTP) at Siteman Cancer Center (STTP; April 2021)
Liquid Biopsy MRD Detection Eyed as Decision Tool for Oligometastatic Colorectal Cancer Patients (genomeweb; March 28, 2021)
ctDNA MRD detection and personalized oncogenomic analysis in colorectal cancer (genomeweb Webinar; March 23, 2021)
Liquid biopsy for colorectal cancer could guide therapy for tumors (EurekAlert; Feb 12, 2021)
Liquid biopsy for colorectal cancer could guide treatment (Siteman News; Feb 2021)
Liquid biopsy for colorectal cancer: Blood and urine samples identify disease that lingers after initial therapy (WashU News; Feb 12, 2021)
Liquid biopsy for colorectal cancer could guide treatment (NewsWise; Feb 12, 2021)
Dr. Chaudhuri leads team selected to win Wash U Leadership & Entrepreneurship Acceleration Program (Skandalaris Ctr News; Dec 14, 2020)
Dr. Chaudhuri is a recipient of the V Foundation V Scholar Award (Siteman News; Nov 24, 2020)
Chaudhuri receives V Scholar Award (WashU Radiation Oncology Departmental News; Nov 19, 2020)
Dr. Aadel Chaudhuri awarded the V Scholar Award from the V Foundation (WashU News; Nov 19, 2020)
Dr. Aadel Chaudhuri presents at the European Association for Cancer Research (EACR) Liquid Biopsy Virtual Event (EACR; Nov 19, 2020)
Cell-Free DNA Analysis Could Aid in Detection, Optimal Management of Resistant Metastatic Prostate Cancer (OncLive News; Aug 18, 2020)
Conversation with Aadel Chaudhuri MD PhD Part 1 | Part 2 | Part 3 (Cancer Research Foundation; July 22, 2020)
Blood test for metastatic prostate cancer could suggest better treatment options (Siteman News; June 18, 2020)
The Chaudhuri lab’s ctDNA analysis and enrollment protocol titled “Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors” is now on ClinicalTrials.gov under ID# NCT04354064 (ClinicalTrials.gov; April 2020)
Aadel Chaudhuri MD PhD quoted by The Scientist regarding his perspective on conference cancellations in the wake of Coronavirus (The Scientist; March 2020)
Aadel Chaudhuri MD PhD receives a grant from the Institute of Clinical and Translational Sciences to research urine tumor DNA in bladder cancer (Wash U Radiation Oncology News; Jan 2020)
Alvin J. Siteman fund grants $600,000 to Aadel Chaudhuri MD PhD, Chris Maher PhD, and Russell Pachynski MD for advanced-stage prostate cancer research (Siteman News; Dec 2019)
Nadja Pejovic, medical student in Dr. Chaudhuri’s lab, delivers an oral presentation at the Radiation Research Society meeting in the session Imaging and Circulating Biomarkers of Radiation Response (Wash U Rad Onc News; Nov 2020)
Aadel Chaudhuri MD PhD quoted in Cancer Discovery article on the recent TRACERx papers published in Nature Medicine (Cancer Discovery; Nov 2019)
Aadel Chaudhuri MD PhD mentioned as part of the team led by Aaron Newman PhD that developed the CIBERSORTx computational tool for high-resolution in silico tissue dissection (Stanford Medicine News; May 2019)
Aadel Chaudhuri MD PhD awarded a NCI K08 award to study ctDNA as a liver cancer biomarker (Wash U Rad Onc News; March 2019)
Aadel Chaudhuri MD PhD mentioned as part of the team behind urine DNA test for bladder cancer detection (Stanford Medicine News; Jan 2019)
Aadel Chaudhuri MD PhD named a 2018 CRF Young Investigator Award winner (Cancer Research Foundation; Dec 2018)
Aadel Chaudhuri MD PhD interviewed on using liquid biopsies to assess radiotherapy response (Imaging Technology News; Nov 2018)
Aadel Chaudhuri MD PhD named 2018 awardee of the Pancreatic Cancer Career Enhancement Program (SPORE; July 2018)
Aadel Chaudhuri MD PhD wins Roentgen Research Award (RSNA; July 2018)
Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer (Cancer Discovery; Dec 2018)
Video interview of Aadel Chaudhuri MD PhD and Maximilian Diehn MD PhD: ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation Therapy (cancerNetwork; Nov 14, 2017)
Lung Cancer Recurrence, Predictable at Last? (Inside Science; Nov 8, 2017)
Blood Test for Tumor Cell DNA May Help Predict Localized NSCLC (Oncology Times; Nov 2017)
ASTRO presents award for top resident conference abstract to Aadel Chaudhuri MD PhD (HemOnc Today; Oct 15, 2017)
ASTRO 2017: Predicting Response to Lung Cancer Treatment With Circulating Tumor DNA Analysis (JNCCN360; Oct 2, 2017)
Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment (Imaging Technology News; Sep 29, 2017)
Predicting lung cancer recurrence by analyzing circulating tumor DNA (Scope, Stanford Medicine’s blog; Sep 28, 2017)
Liquid Biopsy May Show Poor Prognosis in Early NSCLC (Medpage Today; Sep 27, 2017)
Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment (The ASCO Post; Sep 26, 2017)
Biomarker blood test predicts survival following localized lung cancer treatment (Markets Insider; Sep 24, 2017)
Biomarker blood test predicts survival following localized lung cancer treatment (ASTRO; Sep 23, 2017)
ASTRO honors 43 researchers including Aadel Chaudhuri MD PhD who won the Clinical/Basic Science Research Award for top resident abstract at the 2017 Annual Meeting (ASTRO; Aug 30, 2017)
Does Plasma-Based Molecular Testing Have a Role in the Routine Care of Lung Cancer? (Clinical Advances in Hematology & Oncology; Aug 2017)
2017 Conquer Cancer Foundation Grants and Awards Ceremony honors Aadel Chaudhuri MD PhD for winning Young Investigator Award (ASCO; June 4, 2017)
Aadel Chaudhuri MD PhD wins RSNA Research Resident/Fellow Grant (RSNA; March 2017)